Načítá se...
Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer
BACKGROUND: The purpose of this study was to assess the efficacy of Bacillus Calmette-Guerin (BCG) therapy after a second transurethral resection (TUR) in new onset high-grade T1 bladder cancer. METHODS: From January 2008 to September 2013, 207 patients with new onset high-grade T1 bladder cancer af...
Uloženo v:
| Vydáno v: | BMC Urol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4769574/ https://ncbi.nlm.nih.gov/pubmed/26920373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-016-0126-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|